Converge Bio
About:
Converge Bio integrates Generative AI with biological data.
Website: https://converge-bio.com/
Top Investors: TLV Partners
Description:
Converge Bio integrates Generative AI with biological data. Converge Bio mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Total Funding Amount:
$5.5M
Headquarters Location:
Wilmington, Delaware, United States
Founded Date:
2024-01-01
Founders:
Dov Gertz, Oded Kalev
Number of Employees:
11-50
Last Funding Date:
2024-11-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai